0001209191-19-032432.txt : 20190523
0001209191-19-032432.hdr.sgml : 20190523
20190523181156
ACCESSION NUMBER: 0001209191-19-032432
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190523
FILED AS OF DATE: 20190523
DATE AS OF CHANGE: 20190523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRYSKA DAVID W
CENTRAL INDEX KEY: 0001202335
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 19851458
MAIL ADDRESS:
STREET 1: 749 N MARY AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-23
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001202335
GRYSKA DAVID W
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400
DURHAM
NC
27703
1
0
0
0
Common Stock
2019-05-23
4
A
0
1750
0.00
A
1750
D
Common Stock
1996
I
By the Gryska Family Trust
Stock Option (right to buy)
39.44
2019-05-23
4
A
0
7800
0.00
A
2029-05-23
Common Stock
7800
7800
D
Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on May 23, 2020.
Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of May 23, 2019.
/s/ John LaRocca, Attorney-in-Fact for David W. Gryska
2019-05-23